Lisa Schulmeister

Monday, June 11, 2018
Chemotherapy-induced peripheral neuropathy (CIPN) is a potentially long-lasting adverse effect of cancer treatment for survivors of childhood cancer.
Monday, June 04, 2018
Game-changing data published in the New England Journal of Medicine and presented during the 2018 ASCO Annual Meeting indicated that many women with HR+, HER2–, axillary node–negative breast cancer would see no significant benefit to having chemotherapy in addition to endocrine therapy.
Wednesday, May 30, 2018
A general lack of understanding of biosimilar drug terminology among clinicians, constantly evolving regulatory guidance, and the processes of prescribing and dispensing biosimilars is concerning, says the American Society of Clinical Oncology.
Monday, May 21, 2018
Researchers from the National Cancer Institute (NCI) used data from its Health Information National Trends Survey to assess knowledge of, and beliefs about, cancer screening.
Monday, May 07, 2018
More than two thousand nurses who self-assessed their knowledge and confidence in their abilities to identify and intervene with caregivers of patients with cancer shows significant room for improvement.
Monday, April 23, 2018
Incidences of merkel cell carcinoma, a rare skin cancer, increased 95% between 2000 and 2013, and are expected to rise further in the future due to the aging US population.

Monday, April 16, 2018
To address the shortage of common IV fluids, many healthcare facilities are now rationing IV fluids and prioritizing their use.
Monday, April 09, 2018
The American Society of Clinical Oncology released guidelines on management of immune-related adverse effects in patients treated with immune checkpoint inhibitor therapy.
Monday, April 02, 2018
Behavioral counseling interventions are of moderate benefit in increasing sun protection behaviors in children, adolescents, and young adults with fair skin types.
Monday, March 19, 2018
A group of researchers in the northeast United States conducted a study to explore how women become informed about breast cancer surgery options.
Monday, March 12, 2018
Breast cancer survivors who exercise could reduce their risk of cardiovascular events, stroke, and diabetes, study shows. 
Monday, March 05, 2018
ASCO releases its annual report highlighting progress, trends, and future directions in cancer practice and research.
Monday, February 26, 2018
Survivors of childhood cancer could be up to 20 times more likely to develop ischemic heart disease or to have strokes than their siblings. To determine their level of risk, researchers used a prediction model that included factors like gender, type of chemotherapy, and radiotherapy exposure to the head, neck, or chest.
Monday, February 19, 2018
Smoking prevention programs need to include warnings that the risk of “trying” a cigarette can lead to daily smoking, and that 69% of people in global survey data who have tried a cigarette became smokers.
Wednesday, February 07, 2018
To ensure the adequate availability of IV solutions that may be in high demand during the flu season, the Food and Drug Administration (FDA) extended the expiration dates of some IV products after Baxter, a major IV solution manufacturer, submitted safety data that indicated that extended expiration dates meet FDA safety standards. 
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN
Blog Info
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN is an oncology nursing consultant and editor-in-chief of Oncology Nursing News.
Author Bio
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN, is the Editor-in-Chief for OncLive Nursing. She is an oncology nursing consultant and adjunct assistant professor of nursing at Louisiana State Health Sciences Center in New Orleans, LA. She provides continuing nursing education to nurses across the Unites States, is active in several professional nursing organizations, and is intrigued by the many ways nurses use technology to communicate.
Blog Archives
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.